Alpha Tau Medical (NASDAQ:DRTS) vs. Tenon Medical (NASDAQ:TNON) Critical Contrast

Tenon Medical (NASDAQ:TNONGet Free Report) and Alpha Tau Medical (NASDAQ:DRTSGet Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Earnings & Valuation

This table compares Tenon Medical and Alpha Tau Medical”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tenon Medical $3.32 million 2.29 -$15.58 million ($27.23) -0.09
Alpha Tau Medical N/A N/A -$29.16 million ($0.45) -5.82

Tenon Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Tenon Medical and Alpha Tau Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical 0 0 2 0 3.00
Alpha Tau Medical 0 0 2 0 3.00

Tenon Medical currently has a consensus price target of $5.50, suggesting a potential upside of 127.27%. Alpha Tau Medical has a consensus price target of $8.00, suggesting a potential upside of 205.34%. Given Alpha Tau Medical’s higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than Tenon Medical.

Profitability

This table compares Tenon Medical and Alpha Tau Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tenon Medical -413.88% -1,785.88% -164.26%
Alpha Tau Medical N/A -38.62% -29.89%

Insider and Institutional Ownership

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 4.7% of Tenon Medical shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

Tenon Medical has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500.

Summary

Alpha Tau Medical beats Tenon Medical on 6 of the 11 factors compared between the two stocks.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Alpha Tau Medical

(Get Free Report)

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.